28.09.2016 Views

Hydrolife Magazine October/November 2016 (USA Edition)

There is a lot of healing in this issue of Hydrolife. As medicinal marijuana gains acceptance in more jurisdictions, more stories are coming to the forefront revealing how cannabis healed a person where traditional drugs could not, or could but with severe side effects. We all want that miracle cure to be found where everybody is safe, where everybody is happy and where everybody is healthy.

There is a lot of healing in this issue of Hydrolife. As medicinal marijuana gains acceptance in more jurisdictions, more stories are coming to the forefront revealing how cannabis healed a person where traditional drugs could not, or could but with severe side effects. We all want that miracle cure to be found where everybody is safe, where everybody is happy and where everybody is healthy.

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

live<br />

by Kyle L. Ladenburger<br />

Contributions<br />

OVER<br />

Compassion?<br />

Kyle L. Ladenburger<br />

examines the struckdown<br />

bill that would<br />

have opened the door<br />

for FDA trials designed<br />

to examine the efficacy<br />

of using MMJ to battle<br />

the opiate epidemic.<br />

In May <strong>2016</strong>,<br />

the United States House Rules Committee<br />

took into consideration a bill designed to<br />

create a task force to investigate current<br />

practices of pain management and pain<br />

medication prescribing in an effort to<br />

help combat the ongoing opioid epidemic.<br />

The task force will be comprised of<br />

several government agencies including<br />

the Drug Enforcement<br />

Administration (DEA),<br />

the Food & Drug Administration<br />

(FDA) and the<br />

Office of National Drug<br />

Control Policy.<br />

Two proposed amendments<br />

to the bill were<br />

brought to the floor that<br />

would have included<br />

investigations into the efficacy<br />

and potential of medicinal cannabis<br />

as an alternative to opioid painkillers and<br />

both were immediately denied.<br />

The first amendment was from Republican<br />

representative Dana Rohrbacher<br />

(California) and would have required the<br />

task force to study the potential for marijuana<br />

to serve as an alternative to opioids<br />

for pain management.<br />

The second amendment, brought<br />

forth by Democrat representative<br />

Jared Polis (Colorado), would have required<br />

the Centers for Disease Control<br />

& Prevention (CDC) and the National<br />

Institutes of Health (NIH) to investigate<br />

the differences between medical<br />

applications of marijuana and opioids<br />

for pain management. Representative<br />

Polis’s amendment also required an<br />

official study of opioid overdose rates<br />

“Two proposed amendments to the bill were<br />

brought to the floor that would have included<br />

investigations into the efficacy and potential of<br />

medicinal cannabis as an alternative to opioid<br />

painkillers and both were immediately denied.”<br />

between states that do not allow medicinal<br />

cannabis use and those that<br />

do. Recent studies have shown that on<br />

average opioid painkiller overdose is<br />

almost 25 per cent lower in states with<br />

medicinal cannabis laws.<br />

The problem? Both amendments were<br />

quietly voted down as the committee<br />

ruled them to be out of order.<br />

66<br />

grow. heal. live. enjoy.<br />

myhydrolife.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!